BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29911900)

  • 1. Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA.
    Morrison VA; Bell JA; Hamilton L; Ogbonnaya A; Shih HC; Hennenfent K; Eaddy M; Shou Y; Galaznik A
    Future Oncol; 2018 Oct; 14(25):2627-2642. PubMed ID: 29911900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA.
    Ren J; Asche CV; Shou Y; Galaznik A
    J Comp Eff Res; 2019 Apr; 8(6):393-402. PubMed ID: 30855175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma.
    Maziarz RT; Hao Y; Guerin A; Gauthier G; Gauthier-Loiselle M; Thomas SK; Eldjerou L
    Leuk Lymphoma; 2018 May; 59(5):1133-1142. PubMed ID: 28933643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
    Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
    Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
    Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
    Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France.
    Mounié M; Costa N; Conte C; Petiot D; Fabre D; Despas F; Lapeyre-Mestre M; Laurent G; Savy N; Molinier L
    J Med Econ; 2020 Mar; 23(3):235-242. PubMed ID: 31876205
    [No Abstract]   [Full Text] [Related]  

  • 7. Costs of relapsed diffuse large B-cell lymphoma among Medicare patients.
    Huntington S; Keshishian A; McGuire M; Xie L; Baser O
    Leuk Lymphoma; 2018 Dec; 59(12):2880-2887. PubMed ID: 29936866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost associated with hematopoietic stem cell transplantation: a retrospective claims data analysis in Germany.
    Mayerhoff L; Lehne M; Hickstein L; Salimullah T; Prieur S; Thomas SK; Zhang J
    J Comp Eff Res; 2019 Jan; 8(2):121-131. PubMed ID: 30517020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
    Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
    Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort.
    Wang HI; Smith A; Aas E; Roman E; Crouch S; Burton C; Patmore R
    Eur J Health Econ; 2017 Mar; 18(2):255-267. PubMed ID: 26969332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020-2025.
    Kanas G; Ge W; Quek RGW; Keeven K; Nersesyan K; Jon E Arnason
    Leuk Lymphoma; 2022 Jan; 63(1):54-63. PubMed ID: 34510995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric follicular lymphoma in Japan.
    Kobayashi R; Tanaka F; Nakazawa A; Ueyama JI; Sunami S; Mitsui T; Koga Y; Mori T; Osumi T; Fukano R; Ohki K; Sekimizu M; Fujita N; Kamei M; Mori T;
    Int J Hematol; 2017 Jun; 105(6):849-853. PubMed ID: 28271414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diffuse large B-cell lymphoma developed newly after 9-year remission of a follicular lymphoma].
    Hirano T; Tsuji T; Yamasaki H; Toyozumi Y; Arima N; Tsuda H
    Rinsho Ketsueki; 2016 Feb; 57(2):171-4. PubMed ID: 26935635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of illness of follicular lymphoma and marginal zone lymphoma.
    Monga N; Nastoupil L; Garside J; Quigley J; Hudson M; O'Donovan P; Parisi L; Tapprich C; Thieblemont C
    Ann Hematol; 2019 Jan; 98(1):175-183. PubMed ID: 30315345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
    Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
    J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of Diffuse Large B-cell Lymphoma From Follicular Lymphoma Using Texture Analysis on Conventional MR Images at 3.0 Tesla.
    Wu X; Sikiö M; Pertovaara H; Järvenpää R; Eskola H; Dastidar P; Kellokumpu-Lehtinen PL
    Acad Radiol; 2016 Jun; 23(6):696-703. PubMed ID: 26976622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost burden of diffuse large B-cell lymphoma.
    Harkins RA; Patel SP; Flowers CR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):645-661. PubMed ID: 31623476
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.
    Griffiths RI; Gleeson ML; Mikhael J; Dreyling MH; Danese MD
    Cancer; 2012 Dec; 118(24):6079-88. PubMed ID: 22648454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.